The Management Board and the Supervisory Board of CompuGroup Medical AG identify with the objectives of the German Corporate Governance Code of promoting responsible and transparent management and control oriented to a sustainable increase in shareholder value.
Investors and capital market participants are to be provided consistent, timely and precise information simultaneously. CompuGroup Medical, as an international company with investors across the globe, publishes all news and press releases in English as well as German.
The Investor Relations section of the company’s corporate website www.cgm.com is an important tool containing up-to-date information on the company’s financial performance and stock market information. User may also find financial reports, an updated financial calendar, detailed company information and other important data for the financial markets. In conjunction with the release of its interim and full year financial results, CGM gives public presentations to investors, analysts and press.
During the year, CompuGroup Medical held numerous physical meetings and phone calls with German and international investors and analysts and participated in international capital market conferences. The cities covered during road shows and conferences in 2013 include: Amsterdam, Boston, Frankfurt, Geneva, London, Milano, Munich, New York, Paris and Zurich.
CGM also held telephone conferences and analyst meetings when publishing quarterly results. At the world’s largest medical trade fair MEDICA in Düsseldorf CompuGroup Medical held an investor and analyst conference in November 2013. In addition to the publication of CGM’s Q3 results, the company presented products and services from various business units.
At the end of the year, the number of analysts that regularly follow CompuGroup Medical amounted to seven, all of them based in Germany. Commerzbank AG started covering the stock in June 2013, Landesbank Baden-Württemberg in November 2013. With three buy, one neutral and three hold recommendations, the analysts presented a positive view of the CompuGroup Medical share. The forecast price targets ranged from EUR 17.00 to EUR 21.00 at the end of 2013.